Alkanesulfonanilide derivatives and pharmaceutically acceptable

Details Alkanesulfonanilide derivatives and pharmaceutically acceptable Alkanesulfonanilide derivatives and pharmaceutically acceptable

1981-12-02

1983-09-13

Waltz, Thomas A.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

564 99, C07C14374, A61K 3118

Patent

active

044042248

ABSTRACT:
A method for increasing the growth rate and/or improving the lean meat to fat ratio in farm and domestic animals. An effective amount of an alkanesulfonanilide derivative, pharmaceutically acceptable acid addition or metal salt thereof is administered either orally or parenterally to animals. Novel 2'hydroxy-5'-[1-alkoxy-2-(alkyl-, dialkyl- or aralkylamino)ethyl]-alkanesulfonanilides are described.

REFERENCES:
patent: 3341584 (1967-09-01), Lareen et al.
patent: 3660487 (1972-05-01), Lareen et al.
patent: 3701808 (1972-10-01), Hartley et al.
patent: 3801631 (1974-04-01), Comer et al.
Riggilo et al., CA 77:56558v (1972).

Affiliated with

Also associated with

Rating

Alkanesulfonanilide derivatives and pharmaceutically acceptable does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkanesulfonanilide derivatives and pharmaceutically acceptable , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanesulfonanilide derivatives and pharmaceutically acceptable will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1729855